Skip to main content
OpenTrials
Completed

NCT Number: NCT00801437

Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.

This study is designed to evaluate the safety and tolerability of Xalacom in patients with primary glaucoma

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma, Open-Angle Eye Diseases Glaucoma Ocular Hypertension

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Pfizer Investigational Site, Banovce N. Bebravou, Slovakia

Loading trial locations.

About this study

according to physicians decision, patients who met inclusion and exclusion criteria and sign the ICD

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • primary open angle glaucoma
  • ocular hypertension
  • age >18 years

Exclusion criteria

  • bradycardia
  • obstructive pulmonary disease
  • hypersensitivity to the drug

Treatment and study plan

Xalacom

Drug

Xalacom 1 drop into the affected eye daily

Primary outcomes

  1. Incidence of ocular hyperemia

    Time frame: 12 months

  2. safety of treatment

    Time frame: 12 months

Secondary outcomes

  1. effectiveness in IOP lowering

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Industry

Registry information

Official study title

Non Interventional Study in Slovak Patients With Primary Open Angle Glaucoma and/or Ocular Hypertension Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy Due to Ineffectivity or Intolerance.

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Dec 3, 2008
Registry last updated
Feb 18, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.